ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.175,21
1,01%
S&P 500
5.180,74
1,03%
Dow Jones
38.852,27
0,46%
Euro vs US Dollar
1,07676
0,00%
Bitcoin
63.347,18
0,29%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Liminal BioSciences Inc (LMNL)

  7. Liminal BioSciences Inc (LMNL) News

LMNL

Liminal BioSciences (LMNL)

Liminal BioSciences Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:LMNL
DatumZeitQuelleÜberschriftSymbolFirma
06/10/202314h30Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:LMNLLiminal BioSciences Inc
27/09/202322h05Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:LMNLLiminal BioSciences Inc
27/09/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:LMNLLiminal BioSciences Inc
27/09/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:LMNLLiminal BioSciences Inc
27/09/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:LMNLLiminal BioSciences Inc
26/09/202315h12Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:LMNLLiminal BioSciences Inc
26/09/202315h08Edgar (US Regulatory)Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securitiesNASDAQ:LMNLLiminal BioSciences Inc
26/09/202315h07Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:LMNLLiminal BioSciences Inc
26/09/202315h04Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:LMNLLiminal BioSciences Inc
26/09/202314h57Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:LMNLLiminal BioSciences Inc
26/09/202314h55Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:LMNLLiminal BioSciences Inc
26/09/202314h54Edgar (US Regulatory)Form SC 13E3/A - Going private transaction by certain issuers: [Amend]NASDAQ:LMNLLiminal BioSciences Inc
26/09/202314h16Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:LMNLLiminal BioSciences Inc
26/09/202314h00PR Newswire (US)LIMINAL BIOSCIENCES ANNOUNCES COMPLETION OF THE PLAN OF ARRANGEMENT WITH STRUCTURED ALPHA LPNASDAQ:LMNLLiminal BioSciences Inc
26/09/202314h00PR Newswire (Canada)LIMINAL BIOSCIENCES ANNOUNCES COMPLETION OF THE PLAN OF ARRANGEMENT WITH STRUCTURED ALPHA LPNASDAQ:LMNLLiminal BioSciences Inc
19/09/202322h43Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:LMNLLiminal BioSciences Inc
19/09/202322h34PR Newswire (US)LIMINAL BIOSCIENCES RECEIVES FINAL COURT ORDER FOR PLAN OF ARRANGEMENT WITH STRUCTURED ALPHA LPNASDAQ:LMNLLiminal BioSciences Inc
19/09/202322h22PR Newswire (Canada)LIMINAL BIOSCIENCES RECEIVES FINAL COURT ORDER FOR PLAN OF ARRANGEMENT WITH STRUCTURED ALPHA LPNASDAQ:LMNLLiminal BioSciences Inc
19/09/202322h22PR Newswire (US)LIMINAL BIOSCIENCES RECEIVES FINAL COURT ORDER FOR PLAN OF ARRANGEMENT WITH STRUCTURED ALPHA LPNASDAQ:LMNLLiminal BioSciences Inc
15/09/202318h03PR Newswire (US)LIMINAL BIOSCIENCES SHAREHOLDERS APPROVE PLAN OF ARRANGEMENT WITH STRUCTURED ALPHA LPNASDAQ:LMNLLiminal BioSciences Inc
15/09/202318h02Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:LMNLLiminal BioSciences Inc
15/09/202317h29PR Newswire (US)LIMINAL BIOSCIENCES SHAREHOLDERS APPROVE PLAN OF ARRANGEMENT WITH STRUCTURED ALPHA LPNASDAQ:LMNLLiminal BioSciences Inc
15/09/202317h29PR Newswire (Canada)LIMINAL BIOSCIENCES SHAREHOLDERS APPROVE PLAN OF ARRANGEMENT WITH STRUCTURED ALPHA LPNASDAQ:LMNLLiminal BioSciences Inc
12/09/202314h38Edgar (US Regulatory)Form SC 13E3/A - Going private transaction by certain issuers: [Amend]NASDAQ:LMNLLiminal BioSciences Inc
12/09/202314h02Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:LMNLLiminal BioSciences Inc
12/09/202314h02PR Newswire (US)LIMINAL BIOSCIENCES FILES AMENDED SCHEDULE 13E-3 AND SUPPLEMENT TO THE MANAGEMENT INFORMATION CIRCULARNASDAQ:LMNLLiminal BioSciences Inc
12/09/202313h45PR Newswire (Canada)LIMINAL BIOSCIENCES FILES AMENDED SCHEDULE 13E-3 AND SUPPLEMENT TO THE MANAGEMENT INFORMATION CIRCULARNASDAQ:LMNLLiminal BioSciences Inc
12/09/202313h45PR Newswire (US)LIMINAL BIOSCIENCES FILES AMENDED SCHEDULE 13E-3 AND SUPPLEMENT TO THE MANAGEMENT INFORMATION CIRCULARNASDAQ:LMNLLiminal BioSciences Inc
16/08/202323h20Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:LMNLLiminal BioSciences Inc
16/08/202323h20PR Newswire (US)LIMINAL BIOSCIENCES OBTAINS INTERIM ORDER FOR PROPOSED ARRANGEMENT WITH STRUCTURED ALPHA LPNASDAQ:LMNLLiminal BioSciences Inc
 Showing the most relevant articles for your search:NASDAQ:LMNL

Kürzlich von Ihnen besucht

NYSE
DIS
Walt Disney
DBI
SDXP
SDAX
COIN
SOLUSD
Solana
TG
NOV
Novo Nordisk
NASDAQ
MSFT
Microsoft
USOTC
DTEGY
Deutsche Telekom (QX)
AMEX
XLV
Health Care Select Sector
FX
EURJPY
Euro vs Yen
NYSE
NKE
Nike
TG
432
Arbor Metals
NYSE
MCD
McDonalds
NYSE
JPM
JP Morgan Chase
TG
BAS
BASF
TG
BAYN
Bayer
NASDAQ
GOOGL
Alphabet
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten